Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible for creating antibodies that help the body fight infections. Once the myeloma ...

The dosing of these two patients demonstrates Cellares’ GMP manufacturing and supply chain capabilities with their automated platform.

As cell and gene therapies (CGTs) continue to receive regulatory approvals at an accelerating pace, health care institutions ...

Once built to fight cancer, CAR‑T therapy is now offering new hope for patients with severe autoimmune disease.

Immune system overreactions may be the true culprit of cardiac illness—and lifesaving drugs can calm them down ...

Researchers showed that extracellular vesicles from menstrual cells stimulate cartilage repair. The new approach offers a ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

Researchers found that regulatory T cells are reduced and functionally altered in children with autism, contributing to ...

Researchers from the Cyprus Institute of Neurology and Genetics and collaborators report the development of a gene silencing therapy for Charcot-Marie-Tooth type 1A.

Scientists transplant photosynthetic nanoparticles into rats and rabbits with degenerative diseases to boost energy, restore ...

Postdoctoral training is a defining stage in a scientist’s career, offering the mentored research experience and professional ...

Funding received in the initial years after an investigator first establishes their research lab can be pivotal in helping to ...